China Resources Medical (HKG:1515) booked 495.9 million yuan in attributable profit for 2025, falling from 565.9 million yuan in 2024, according to a Hong Kong bourse filing Tuesday.
Shares of the medical firm gained over 2% in late morning trade Wednesday.
Earnings per share were 0.39 yuan, compared with 0.45 yuan in the prior year.
Revenue fell to 9.18 billion yuan from 9.85 billion yuan in 2024.
The company also declared a dividend of 0.084 yuan per share, payable July 22 to shareholders of record on June 18.